High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer

被引:0
作者
K K Mauland
J Trovik
E Wik
M B Raeder
T S Njølstad
I M Stefansson
A M Øyan
K H Kalland
T Bjørge
L A Akslen
H B Salvesen
机构
[1] Haukeland University Hospital,Department of Obstetrics and Gynaecology
[2] University of Bergen,Department of Clinical Medicine
[3] Section for Pathology,Department of Pathology
[4] The Gade Institute,Department of Microbiology
[5] University of Bergen,Department of Public Health and Primary Health Care
[6] Haukeland University Hospital,undefined
[7] Haukeland University Hospital,undefined
[8] University of Bergen,undefined
[9] Norwegian Institute of Public Health,undefined
来源
British Journal of Cancer | 2011年 / 104卷
关键词
body mass index; endometrial carcinoma; prognosis; progesterone receptor;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:921 / 926
页数:5
相关论文
共 155 条
[1]  
Amant F(2005)Endometrial cancer Lancet 366 491-505
[2]  
Moerman P(1996)Obesity and prognosis in endometrial cancer Am J Obstet Gynecol 174 1171-1179
[3]  
Neven P(2007)Body size in relation to cancer of the uterine corpus in 1 million Norwegian women Int J Cancer 120 378-383
[4]  
Timmerman D(1983)Two pathogenetic types of endometrial carcinoma Gynecol Oncol 15 10-17
[5]  
Van Limbergen E(2001)Endometrial cancer in women 40 years old or younger Gynecol Oncol 83 388-393
[6]  
Vergote I(2009)Biologic markers in endometrial cancer treatment APMIS 117 693-707
[7]  
Anderson B(2008)Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma Br J Cancer 98 1662-1669
[8]  
Connor JP(2008)GATA3 expression in estrogen receptor alpha-negative endometrial carcinomas identifies aggressive tumors with high proliferation and poor patient survival Am J Obstet Gynecol 199 543.e1–7-1822
[9]  
Andrews JI(2006)Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium J Natl Med Assoc 98 1814-1251
[10]  
Davis CS(2001)Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors Am J Pathol 158 1245-28